Technology Valuation Course

AUTM Annual Meeting

Technology Valuation Course

Sunday, February 19
7:30 a.m. – 4 p.m.

 

AUTM’s Technology Valuation Course teaches the fundamental principles of how to construct the various financial terms that go into a license. The course examines concepts such as valuation versus pricing and risk, as well as a series of valuation methodologies, including cost, income, industry standards (comparables), rules of thumb, discounted cash flow and equity. The first segment concludes with a review of payment structures within a license and shows the financial flows under a typical academic-stage life sciences license. 

The course goes on to focus on practical applications including case studies. The class is divided into groups to develop license term proposals for the discussion of two technologies. 

If you have, or will have, responsibility for negotiating licenses, or would like to learn more about the process, the Licensing Valuation Course is ideal. Attendees should have a basic familiarity with the structure and payment mechanisms used in a license and be proficient in web searching and Excel spreadsheets.

As a prerequisite to the course, attendees will have access to the Technology Valuation Four-Part webinar series, a $325 value, and be expected to watch these videos before the start of the course. 



Annual Meeting Sponsors

AstraZeneca
Amster, Rothstein & Ebenstein LLP
Wellspring
KPPB
Osage University Partners
PhRMA
Casimir Jones, SC
Michael Best & Friedrich
Cayuse
NIIMBL
Boehringer Ingelheim Pharmaceuticals Inc.
Nixon Peabody
Parker Highlander PLLC
LevelSet Capital
Merck
Marshall Gerstein
InfoEd
Blank Rome LLP
KISSPlatform Europe BV
Novartis
LockeLord
Elsevier
Quarles & Brady LLP
Computer Packages, Inc.
Boehringer Ingelheim
Schwegman Lundberg & Woessner
NYU Langone
Berggren
RWS
Fox Rothschild LLP